237 related articles for article (PubMed ID: 21091667)
21. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
[TBL] [Abstract][Full Text] [Related]
22. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis.
Granito A; Yang WH; Muratori L; Lim MJ; Nakajima A; Ferri S; Pappas G; Quarneti C; Bianchi FB; Bloch DB; Muratori P
Am J Gastroenterol; 2010 Jan; 105(1):125-31. PubMed ID: 19861957
[TBL] [Abstract][Full Text] [Related]
23. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
[TBL] [Abstract][Full Text] [Related]
25. Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis.
Bassendine MF; Jones DE; Yeaman SJ
Semin Liver Dis; 1997 Feb; 17(1):49-60. PubMed ID: 9089910
[TBL] [Abstract][Full Text] [Related]
26. Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis.
Reig A; Norman GL; Garcia M; Shums Z; Ruiz-Gaspà S; Bentow C; Mahler M; Romera MA; Vinas O; Pares A
Am J Gastroenterol; 2020 Oct; 115(10):1634-1641. PubMed ID: 32467507
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
Itoh S; Ichida T; Yoshida T; Hayakawa A; Uchida M; Tashiro-Itoh T; Matsuda Y; Ishihara K; Asakura H
J Gastroenterol Hepatol; 1998 Mar; 13(3):257-65. PubMed ID: 9570238
[TBL] [Abstract][Full Text] [Related]
28. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis.
Fussey SP; Guest JR; James OF; Bassendine MF; Yeaman SJ
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8654-8. PubMed ID: 3186751
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of autoantibodies directed against nuclear and cytoplasmic antigens in autoimmune liver disease.
McLean F
Br J Biomed Sci; 2013; 70(1):10-4. PubMed ID: 23617092
[TBL] [Abstract][Full Text] [Related]
30. [Meta-analysis of anti-GP210 antibody and anti-SP100 antibody detection for diagnosis of primary biliary cirrhosis].
Deng HM; Hu SL; Chen WX; Huang Y
Zhonghua Gan Zang Bing Za Zhi; 2016 Jan; 24(1):62-8. PubMed ID: 26983392
[TBL] [Abstract][Full Text] [Related]
31. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis.
Klein R; Wiebel M; Engelhart S; Berg PA
Clin Exp Immunol; 1993 May; 92(2):308-16. PubMed ID: 7683589
[TBL] [Abstract][Full Text] [Related]
32. [Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].
Liu HH; Fu JL; Xu J; Luo SQ; Liu ZW; Wang FS
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):233-7. PubMed ID: 23591343
[TBL] [Abstract][Full Text] [Related]
33. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
34. Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay.
Villalta D; Sorrentino MC; Girolami E; Tampoia M; Alessio MG; Brusca I; Daves M; Porcelli B; Barberio G; Bizzaro N;
Clin Chim Acta; 2015 Jan; 438():135-8. PubMed ID: 25172039
[TBL] [Abstract][Full Text] [Related]
35. Probing the mRNA processing body using protein macroarrays and "autoantigenomics".
Yang WH; Bloch DB
RNA; 2007 May; 13(5):704-12. PubMed ID: 17339575
[TBL] [Abstract][Full Text] [Related]
36. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
[TBL] [Abstract][Full Text] [Related]
37. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.
Surh CD; Ahmed-Ansari A; Gershwin ME
J Immunol; 1990 Apr; 144(7):2647-52. PubMed ID: 1690773
[TBL] [Abstract][Full Text] [Related]
38. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens.
Yeaman SJ; Fussey SP; Danner DJ; James OF; Mutimer DJ; Bassendine MF
Lancet; 1988 May; 1(8594):1067-70. PubMed ID: 2896910
[TBL] [Abstract][Full Text] [Related]
39. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
[TBL] [Abstract][Full Text] [Related]
40. Autoantibodies of sera from patients with primary biliary cirrhosis recognize the alpha subunit of the decarboxylase component of human branched-chain 2-oxo acid dehydrogenase complex.
Mori T; Ono K; Hakozaki M; Kasukawa R; Kochi H
J Hepatol; 2001 Jun; 34(6):799-804. PubMed ID: 11451161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
